e-learning
resources
Munich 2006
Monday 04.09.2006
Lung cancer biology and chemosensitivity
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tissue microarray technology for lung cancer characterization using MUC1 and Lewis Y glycoproteins
R. Wiewrodt, L. H. Schmidt, S. Biesterfeld, A. Faldum, A. Kuemmel, K. Single, R. Buhl (Mainz, Germany)
Source:
Annual Congress 2006 - Lung cancer biology and chemosensitivity
Session:
Lung cancer biology and chemosensitivity
Session type:
Oral Presentation
Number:
2014
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Wiewrodt, L. H. Schmidt, S. Biesterfeld, A. Faldum, A. Kuemmel, K. Single, R. Buhl (Mainz, Germany). Tissue microarray technology for lung cancer characterization using MUC1 and Lewis Y glycoproteins. Eur Respir J 2006; 28: Suppl. 50, 2014
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Proteomic analysis of human small cell lung cancer tissues
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009
Differential expressions of MUC1 mucin with various glycosylation during lung development
Source: Annual Congress 2006 - Molecular airway biology
Year: 2006
Gene expression profiling reveal novel biomarkers in non-small cell lung cancer
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
Exploring the 24h-effect of targeted therapies in non-small cell lung cancer from exon array blood profiling using dually constrained correspondence analysis
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
Identification of tumor-associate proteins in stage-I lung squamous cancer by proteomics
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008
A tissue microarray analysis on the role of chromosome 7 multiplication regarding the EGFR expression in non-small cell lung carcinomas
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Comparative analysis of lung cancer driver mutations from FFPE samples and liquid biopsies by IonTorrent next generation sequencing
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013
Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Source: ERS Lung Science Conference 2017
Year: 2017
Fucosylation of serum glycoproteins in lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 458s
Year: 2005
Gene expression profiling of lung adenocarcinoma by microarray analysis
Source: Eur Respir J 2005; 26: Suppl. 49, 93s
Year: 2005
Identifying a tissue specific microRNA molecular signature in lung cancer
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021
Specific lung cancer peptides selected by a subtractive 3D cell-phage display technology
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
Gene expression and
in situ
protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue
Source: Eur Respir J, 56 (3) 2001123; 10.1183/13993003.01123-2020
Year: 2020
Gene expression profile in lung adenocarcinoma and non-cancerous lung tissue
Source: Eur Respir J 2005; 26: Suppl. 49, 456s
Year: 2005
Evolution of microRNA expression during human bronchial squamous carcinogenesis
Source: Eur Respir J 2009; 33: 352-359
Year: 2009
The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP)
Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept